stockrow
Friday 6 November 2026
Export BTCY’s income statement to Excel — free account
Biotricity Inc.
BTCY Healthcare Medical Devices
Biotricity Inc.’s revenue for fiscal 2026 (year ended March 2026) was $16.0 million, up 16.0% from fiscal 2025.
- Revenue
- +10.4%
- EPS
- −66.7%
- Free cash flow
- +235.8%
- Total debt
- +3.48%
Quarter to June 2026, against a year earlier
0.06
0.01
+20.00%
Follow BTCY
Alert me
| Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 3 | 4 | 4 | 3 | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
P/S ratio |
0.41 | 0.53 | 1.07 | 2.51 | 13.49 | 26.56 | 24.69 | 76.29 | — | — |
Altman Z-Score |
(33.34) | (36.88) | (36.38) | (31.17) | (6.62) | (25.86) | (46.76) | (153.33) | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Altman Z″-Score (non-manufacturers) |
(103.06) | (103.00) | (100.93) | (79.55) | (20.94) | (76.12) | (119.70) | (375.48) | — | — |
Beneish M-Score |
(3.24) | (7.50) | (8.37) | (6.19) | (3.17) | (6.04) | (7.99) | — | — | — |
P/Operating CF |
(313.54) | (18.26) | (11.03) | (12.86) | (21.70) | (25.11) | (11.85) | (26.24) | — | — |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
EV/Sales |
2.07 | 2.33 | 2.87 | 4.30 | 13.74 | 27.28 | 25.50 | 78.39 | — | — |
EV/EBITDA |
13.54 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
EV/Operating CF |
(45.99) | (13.49) | (5.16) | (3.06) | (6.93) | (8.33) | (4.60) | (3.09) | — | — |
EV/FCF |
(44.16) | (13.33) | (5.14) | (3.05) | (6.92) | (8.33) | (4.60) | (3.09) | — | — |
Quick Ratio |
0.08 | 0.10 | 0.10 | 0.16 | 2.89 | 0.35 | 0.38 | 0.12 | 1.16 | 0.09 |
Current Ratio |
0.16 | 0.22 | 0.20 | 0.42 | 3.15 | 0.41 | 0.44 | 0.20 | 1.19 | 0.09 |
Net Debt/EBITDA |
10.85 | (49.28) | (3.26) | (1.18) | (0.26) | (0.23) | (0.11) | (0.09) | 0.12 | (0.24) |
Debt/Assets |
413.65% | 446.04% | 378.49% | 273.77% | 84.08% | 104.75% | 106.04% | 176.83% | 0.00% | 328.83% |
Debt/Equity |
(0.77) | (0.79) | (0.71) | (0.90) | (6.54) | (0.68) | (0.71) | (0.49) | 0.00 | (0.36) |
Asset Turnover |
2.65 | 2.38 | 1.94 | 0.83 | 0.72 | 1.05 | 1.14 | 0.56 | 0.00 | 0.00 |
Operating CF/Net income |
0.23 | 0.20 | 0.45 | 0.69 | 0.50 | 0.67 | 0.69 | 0.61 | 0.57 | 0.48 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
Interest Coverage |
0.50 | (0.75) | (2.92) | (8.38) | (13.04) | — | — | — | — | — |
| 9.38% | 37.62% | 58.19% | 177.66% | 673.20% | 334.63% | 474.03% | 1,071.00% | 409.52% | 184.76% | |
| (51.76%) | (206.19%) | (239.76%) | (168.48%) | (286.22%) | (510.78%) | (907.77%) | (1,210.07%) | (1,229.41%) | (2,886.99%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
10.00% | 74.70% | 81.97% | 304.31% | (288.26%) | 269.61% | 602.48% | 474.54% | (6,151.00%) | 176.77% |
Average Days of Receivables |
66.91 | 43.90 | 44.44 | 46.35 | 95.74 | 164.00 | 125.18 | 190.75 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
17.28% | 15.63% | 21.32% | 33.51% | 35.88% | 60.83% | 96.16% | 328.78% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
53.09% | 78.74% | 121.13% | 182.82% | 242.64% | 371.23% | 709.12% | 1,843.97% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.18% | 12.93% | 9.47% | 10.69% | 37.51% | 120.01% | 235.42% | 769.49% | 0.00% | 0.00% |
Graham Net Nets |
(5.38) | (4.51) | (2.56) | (0.90) | (0.03) | (0.08) | (0.10) | (0.06) | — | — |
Graham Number |
1.85 | 4.74 | 11.36 | 9.40 | 5.10 | 7.96 | 4.59 | 3.36 | — | — |
Earnings Yield |
(50.00%) | (197.06%) | (114.68%) | (61.38%) | (29.95%) | (17.95%) | (32.07%) | (28.70%) | — | — |
Free Cash Flow Yield |
(11.43%) | (32.93%) | (52.29%) | (56.20%) | (14.72%) | (12.33%) | (22.46%) | (33.23%) | — | — |
Revenue per Share |
0.59 | 0.64 | 1.34 | 1.11 | 1.01 | 0.54 | 0.24 | 0.07 | 0.00 | 0.00 |
Operating CF per Share |
(0.03) | (0.11) | (0.74) | (1.56) | (2.00) | (1.77) | (1.31) | (0.94) | (0.97) | (0.87) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.03) | (0.11) | (0.74) | (1.56) | (2.01) | (1.77) | (1.31) | (0.94) | (0.97) | (0.87) |
Cash per Share |
0.01 | 0.02 | 0.09 | 0.07 | 1.59 | 0.35 | 0.16 | 0.01 | 0.17 | 0.10 |
Shareholders Equity per Share |
(1.27) | (1.49) | (3.50) | (2.29) | (0.28) | (1.09) | (0.50) | (0.32) | 0.03 | (1.02) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(1.27) | (1.49) | (3.50) | (2.29) | (0.28) | (1.09) | (0.50) | (0.32) | 0.03 | (1.02) |
Free Cash Flow |
(0.72) | (2.38) | (6.69) | (13.55) | (15.19) | (11.08) | (7.86) | (5.22) | (4.87) | (3.75) |
Working Capital |
(31.28) | (16.00) | (18.23) | (6.44) | 10.46 | (6.17) | (2.14) | (1.81) | 0.14 | (4.42) |
Capital Expenditures |
— | — | — | — | (0.03) | — | — | — | — | — |
Net Current Asset Value |
(35.27) | (33.02) | (32.94) | (21.64) | (3.50) | (6.95) | (3.35) | (1.81) | 0.14 | (4.42) |
EV/EBIT |
19.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Price to Operating Income |
3.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
208.83 | 202.69 | 139.67 | 34.86 | 337.76 | 37.54 | 0.35 | — | 0.00 | 0.00 |
Cash ROIC |
9.15% | 36.69% | 81.76% | 933.82% | (63.45%) | (64,050.87%) | (10,511.76%) | 616.82% | (479.40%) | 156.02% |
Accounts Receivable Turnover |
6.97 | 8.82 | 8.96 | 5.97 | 4.34 | 3.37 | 4.08 | 3.27 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.37 | 0.37 | 0.51 | 1.10 | 1.20 | 1.05 | 0.64 | 0.31 | 0.00 | 0.00 |
Inventory Turnover |
2.11 | 1.88 | 1.76 | 2.64 | 5.52 | 11.79 | 16.90 | 6.13 | — | — |
Average Days of Payables |
1,073.78 | 866.95 | 946.50 | 438.53 | 307.60 | 435.53 | 595.94 | 1,511.14 | 0.00 | 0.00 |
Days of Inventory on Hand |
160.55 | 175.99 | 185.05 | 203.24 | 99.89 | 47.09 | 33.56 | 26.54 | — | — |
Average Receivables |
2.30 | 1.56 | 1.35 | 1.62 | 1.76 | 1.00 | 0.35 | 0.12 | 0.02 | 0.01 |
Average Payables |
8.32 | 8.64 | 7.33 | 3.82 | 2.56 | 2.02 | 1.46 | 1.08 | 0.95 | 1.23 |
Average Inventory |
1.45 | 1.72 | 2.11 | 1.59 | 0.56 | 0.18 | 0.06 | 0.06 | — | — |
Average Assets |
6.04 | 5.79 | 6.23 | 11.59 | 10.56 | 3.22 | 1.25 | 0.71 | 0.70 | 0.27 |
Average Common Equity |
(33.35) | (31.74) | (25.66) | (11.00) | (4.49) | (4.92) | (2.39) | (0.80) | (2.11) | (4.23) |
Columns are period end dates · fundamentals updated 2 Nov 2026